Woonbok Chung
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
-
- Epigenetics and DNA Methylation 26
- RNA modifications and cancer 11
- Cancer-related gene regulation 10
- Histone Deacetylase Inhibitors Research 6
- Hematology 12
- Acute Myeloid Leukemia Research 12
- Co-authors
- Jean‐Pierre J. Issa (33 shared papers)Jaroslav Jelı́nek (21 shared papers)Lanlan Shen (9 shared papers)Marcos R. Estecio (11 shared papers)Michael Ittmann (4 shared papers)Bernard Kwabi‐Addo (4 shared papers)Hagop M. Kantarjian (12 shared papers)Minoru Toyota (4 shared papers)
- Journals
- PLoS ONE (6 papers)Cancer Research (6 papers)Blood (5 papers)Cancer (2 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesJapanSouth Korea
In The Last Decade
Woonbok Chung
35 papers receiving 2.7k citations
Woonbok Chung's Hit Papers
Peers
Comparison fields: 5 of 110
- Hematology 386
- Cancer Research 502
- Oncology 846
- Molecular Biology 1.9k
- Pathology and Forensic Medicine 418
Countries citing papers authored by Woonbok Chung
This map shows the geographic impact of Woonbok Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Woonbok Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Woonbok Chung more than expected).
Fields of papers citing papers by Woonbok Chung
This network shows the impact of papers produced by Woonbok Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Woonbok Chung. The network helps show where Woonbok Chung may publish in the future.
Co-authors
The 25 scholars most cited alongside Woonbok Chung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF -Mutated Colorectal Cancer Hit paper breakdown → | 2015 | 513 |
| 2 | Fusobacterium in Colonic Flora and Molecular Features of Colorectal Carcinoma Hit paper breakdown → | 2014 | 354 |
| 3 | 2015 | 210 | |
| 4 | 2007 | 171 | |
| 5 | 2010 | 133 | |
| 6 | 2011 | 127 | |
| 7 | 2008 | 125 | |
| 8 | 2011 | 109 | |
| 9 | 2009 | 106 | |
| 10 | 2008 | 99 | |
| 11 | 2010 | 98 | |
| 12 | 2011 | 90 | |
| 13 | 2006 | 80 | |
| 14 | 2010 | 67 | |
| 15 | 2013 | 63 | |
| 16 | 2011 | 58 | |
| 17 | 2016 | 49 | |
| 18 | 2017 | 49 | |
| 19 | 2016 | 44 | |
| 20 | 2013 | 31 |
About Woonbok Chung
Woonbok Chung is a scholar working on Molecular Biology, Hematology, Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 37 papers that have together received 2.7k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (26 papers), Acute Myeloid Leukemia Research (12 papers), RNA modifications and cancer (11 papers), Cancer-related gene regulation (10 papers), Histone Deacetylase Inhibitors Research (6 papers), Cancer Genomics and Diagnostics (5 papers), Prostate Cancer Treatment and Research (3 papers) and Genetic factors in colorectal cancer (2 papers). The work is most often cited by research in Hematology (386 citations), Cancer Research (502 citations), Oncology (846 citations), Molecular Biology (1.9k citations) and Pathology and Forensic Medicine (418 citations). Woonbok Chung has collaborated with scholars based in United States, Japan and South Korea. Frequent co-authors include Jean‐Pierre J. Issa, Jaroslav Jelı́nek, Lanlan Shen, Marcos R. Estecio, Michael Ittmann, Bernard Kwabi‐Addo, Hagop M. Kantarjian, Minoru Toyota, Yutaka Kondo and Judith Garriga. Their work appears in journals such as PLoS ONE, Cancer Research, Blood, Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.